MetLife (MET) director awarded 1,016 deferred shares as board pay

Rhea-AI Filing Summary

HUBBARD ROBERT GLENN reported acquisition or exercise transactions in this Form 4 filing.

MetLife Inc. director Robert Glenn Hubbard received an equity grant of 1,016 shares of common stock, valued at $87.40 per share, as part of non-management director retainer compensation. He elected to defer receipt of these shares under MetLife’s Deferred Compensation Plan for Non-Management Directors, and now holds 107,573 common shares directly after this award.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider HUBBARD ROBERT GLENN

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,016	$87.40	$89K

Holdings After Transaction: Common Stock — 107,573 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Shares granted: 1,016 shares Grant price: $87.40 per share Shares held after transaction: 107,573 shares

3 metrics

Shares granted 1,016 shares Non-management director equity award on 2026-06-16

Grant price $87.40 per share Valuation for the 1,016-share director award

Shares held after transaction 107,573 shares Director’s direct MetLife common stock holdings post-award

Key Terms

non-management director retainer fees, Deferred Compensation Plan for Non-Management Directors, common stock

3 terms

non-management director retainer fees financial

"non-management director retainer fees and Board Chair retainer fees in MetLife, Inc. common stock"

Deferred Compensation Plan for Non-Management Directors financial

"defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors"

common stock financial

"pay a portion of non-management director retainer fees and Board Chair retainer fees in MetLife, Inc. common stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HUBBARD ROBERT GLENN

(Last) (First) (Middle)

METLIFE, INC.

200 PARK AVENUE

(Street)

NEW YORK NEW YORK 10166

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
METLIFE INC [ MET ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/16/2026		A(1)		1,016	A	$87.4	107,573	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees and Board Chair retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

Remarks:

	/s/ Taylor McInerney Jansen, Attorney-in-fact	06/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did MetLife (MET) director Robert Glenn Hubbard report?

Robert Glenn Hubbard reported an acquisition of 1,016 MetLife common shares. The shares were granted as part of non-management director compensation at a price of $87.40 per share and represent a routine equity award rather than an open-market purchase.

At what price were the MetLife (MET) shares granted to director Robert Glenn Hubbard?

The shares were granted at $87.40 per MetLife common share. This price is used for valuing the 1,016-share equity award that forms part of his non-management director retainer compensation, which he chose to defer under the company’s deferred compensation plan.

How many MetLife (MET) shares does Robert Glenn Hubbard hold after this grant?

After the grant, Robert Glenn Hubbard directly holds 107,573 MetLife common shares. This total includes the newly awarded 1,016 shares that were credited as part of his director compensation and reflects his direct ownership position following the reported transaction.

Was Robert Glenn Hubbard’s MetLife (MET) transaction a market buy or a compensation award?

The transaction was a compensation-related award, not a market purchase. The 1,016 MetLife shares were granted as part of non-management director retainer and Board Chair fees, rather than acquired through an open-market buy order on an exchange.

Did Robert Glenn Hubbard defer his MetLife (MET) director share award?

Yes, he elected to defer receipt of the awarded MetLife shares. According to the disclosure, the director chose to defer the 1,016-share grant under the MetLife Deferred Compensation Plan for Non-Management Directors, affecting when he actually receives the stock.